Small Molecule - Phase 3 or Commercial Support

We can rapidly develop a formulation that is best suited for your drug development program and provide submission-ready documentation.
If you are developing a new drug product or reformulating an existing drug, our team is composed of experts in oral liquid and solid dosage forms, parenteral formulati...

Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product, biologics and phytocannabinoids. Specializing in complex and niche small molecule drug substance and drug product services, including high potent capabilities, we provide support from preclinical to commercial devel...

Setting the stage for the commercial process:• Route or step rebuild
• Process optimization &demonstration
• Impurities assessment & synthesis
• Full structure characterization &elucidation
• Analytical method development &qualification
• Stress studies & ICH st...

Eurofins CDMO is an FDA-approved contract development and manufacturing organization (CDMO) focused on process chemistry, cGMP scale-up and analytical method development for complex, small molecule APIs, including highly potent molecules. Our talented team of Process Research, Analytical, Technology Transf...

Our Operations team has extensive experience in cGMP clinical drug product manufacturing. Our state-of-the-art facilities and cGMP compliant systems are specifically designed for quick-to-clinic operations. Eurofins CDMO’s team of Engineers, Technology Transfer specialists, and Scientists specialize in pro...

Our Formulation Scientists and Process Engineers are experts in poorly soluble compounds and high containment operations. Our formulation development lab and pilot plant suites are specifically designed for high containment and outfitted with cGMP matching technologies. We follow a data driven approach to ...

A wide range of IND enabling drug product services are provided at Eurofins CDMO. Our PhD scientists have extensive experience in material characterization, analytical chemistry and strategies for developing poorly soluble compounds. Our Pre-Formulation laboratory is fitted with a suite of specialized equi...

Eurofins CDMO provides expertise and services in physicochemical characterization of API and intermediates, screening for different API solid forms and salts as well as crystallization process development.

We apply High-Throughput Screening Technology (HTST) for expeditious discovery of new poly...

Join us for an afternoon of science, cocktails and networking at our Sip N Science Mixer on Wednesday, May 9 from 2:00 pm - 4:00 at Booth#414. 

We look forward to seeing you there!

Eurofins CDMO offers analytical services as part of API development as well as stand-alone analytical testing services for projects at various stages in the drug life cycle (pre-clinical to late phase). Our analytical scientists specialize in the development of analytical methods and phase appropriate specifications to ensure control of the synthetic process and quality of API throughout the program.

Eurofins CDMO is an FDA-approved contract development and manufacturing organization (CDMO) focused on process chemistry, cGMP scale-up and analytical method development for complex, small molecule APIs, including highly potent molecules.

Eurofins CDMO is an FDA-approved contract development and manufacturing organization (CDMO) focused on API and Drug Product development and manufacturing services for complex small molecules. IND enabling development of poorly soluble compounds and clinical manufacturing strategies are a core strength at Eurofins CDMO.